GPCM
BIIB icon

Granite Point Capital Management’s Biogen BIIB Stock Holding History

Granite Point Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,000
Closed -$1.73M – 143
2021
Q2 		$1.73M Buy
+5,000
New +$1.51M 0.06% 91

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Granite Point Capital Management's BIIB Position: Q3 2021 in Review

Granite Point Capital Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 5,000 shares — an estimated $1.73M sold.

Granite Point Capital Management first reported a position in BIIB in Q2 2021 and held it in 1 quarter. The position peaked at $1.73M in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Granite Point Capital Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Granite Point Capital Management sold 5,000 Biogen shares in Q3 2021, an estimated $1.73M.
  • Granite Point Capital Management first reported a position in Biogen in Q2 2021 and held it in 1 quarter.
  • Granite Point Capital Management's Biogen position peaked at $1.73M in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Granite Point Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.